Harvard Business Review

APRIL 6, 2017

I help the University of Utah hospital system manage its drug budgets and medication use policies, and in 2015 I got sticker shock. The 1984 Drug Price Competition and Patent Term Restoration Act gave pharmaceutical companies exclusive protections for innovating a new drug. ” And for a while, the system worked well.

System 11

System Pharmaceuticals Company Sample 11

Strategy Driven

NOVEMBER 29, 2016

When it’s time to hire for critical positions within your company, consider the training and certification in military systems offered to service men and women. They are developing programs to support a veteran’s re-entry into the civilian workforce, which often include resources for spouses and children. About the Author.

Agility 50

Agility Pharmaceuticals Self-aware Crisis Management 50

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

JULY 6, 2016

For 78-year-old Tony, 3,4 DAP — which can be obtained at low cost from compounding pharmacies or for free through a compassionate-use program supported by a small privately held company, Jacobus Pharmaceuticals — is a lifesaver. Pharmaceutical companies traditionally invest heavily in research and development.

Price 14

Price Pharmaceuticals Company Health Care 14

Harvard Business Review

DECEMBER 14, 2017

health care system is begging for disruption. Combining an insurance function with a delivery system has ample precedent in health care. Some of the nation’s most innovative, high-performing non-profit health care organizations use this formula. Paul Taylor/Getty Images. It costs way too much ($3.3

Health Care 8

Health Care System Insurance Pharmaceuticals 8

Harvard Business Review

JULY 8, 2016

China has not been a huge technology innovator, despite being the world’s second-largest investor in R&D , but Chinese businesses have found ways to use innovations in processes, business models, and customer experience to their disruptive advantage. This presents Western companies with a fresh challenge.

Business Model 9

Business Model Innovation Company Apparel 9

Harvard Business Review

FEBRUARY 26, 2018

Regeneratives are pharmaceutical cell therapy products that replace or restore cells and tissues lost to disease or aging. “To be able to do that, they need to entice companies to come to Japan, and they need to entice their own pharmaceutical companies to license in and obtain the best.” Agilis Biotherapeutics, a U.S.

Pharmaceuticals 8

Pharmaceuticals Content Licensing Trends 8

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more. This is an incredible moment for innovation.

Innovation 11

Innovation Productivity Products Venture Capitalist 11

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 9

Innovation Short-term Telecommunications Long-term 9

Coaching Tip

MARCH 15, 2011

Transforming time from an adversary into an ally has helped me develop the positive mindset to be able to dust myself off from my own early business failures and build my company, Weatherchem, into the leader in my industry. . All it takes is the desire to be innovative and creative in tackling a problem. Deregulation.

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

Harvard Business Review

FEBRUARY 3, 2017

The business model of research-based pharmaceutical companies is under significant pressure. However, it also reflects stronger pressures to lower medicine costs in traditional pharmaceutical markets. citizens than pharmaceuticals (the sector’s worst showing in 16 years). Mitigate the risk of unethical conduct.

Reputation 8

Reputation Pharmaceuticals Price Business Model 8

Harvard Business Review

FEBRUARY 22, 2011

Editor's note: This post is the first in a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. Lack of consensus among players in a complex system is one of the biggest barriers to innovation. It's a classic change management problem.

Health Care 15

Health Care Innovation Pharmaceuticals Consensus 15

Harvard Business Review

JANUARY 27, 2016

Much fanfare has been paid to the term “disruptive innovation” over the past few years. Disruptive innovations are: Cheaper (from a customer perspective). New technologies, combined with business model innovation, provide the structural cost advantage necessary to take large chunks of the market over time.

Disruptive Innovation 8

Disruptive Innovation Innovation Short-term Long-term 8

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. If it's not, the already big and already rich will dominate innovation. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. Innovating for Value in Health Care. Insight Center. Sponsored by Medtronic.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

First Friday Book Synopsis

MARCH 21, 2012

An entrepreneur and veteran of the computer industry, Frank Moss spent his career bringing innovative technologies to market. Ten years ago he set out to make a broader contribution to the world, leading him to cofound a cancer drug discovery company and then to the MIT Media Lab, where he served as director from 2006 [.].

Entrepreneur 80

Entrepreneur Media Technology Innovation 80

Strategy Driven

MARCH 18, 2011

Further, they need to limit their focus to, at most, six capabilities, and make those capabilities work together as a mutually reinforcing system that perpetuates competitive advantage. That belief stems from having chosen a differentiated way to play that is supported by a strong system of mutually reinforcing capabilities.

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

MARCH 18, 2018

Why the Pharmaceutical Industry Is Booming in Japan. This also includes innovative systems for patient-requested care, promotion of self-medication, cloud-based record availability, and remote monitoring of patients in their homes. Conditional early approval expanded to cover innovative medical devices in July 2017.

Health Care 8

Health Care Industry Pharmaceuticals Content 8

Harvard Business Review

MAY 7, 2015

The convergence of mobile, analytics, context-rich systems, and the cloud, together with an explosion of information, is transforming sales, and enabling buyers and salespeople to engage with each other in more effective and efficient ways. Context rich systems. Cloud Computing and 5. Consider three examples.

Trends 8

Trends Technology Pharmaceuticals Team 8

Harvard Business Review

SEPTEMBER 11, 2014

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Consider the 2×2 matrix below.

Uncertainty 20

Uncertainty Industry Bottom-up Technology 20

Harvard Business Review

APRIL 2, 2018

health care system woefully underperform relative to those made in health care in other countries. To be sure, many factors influence health outcomes and the investments the health care system makes are only one input. In the last half decade, however, several new HCV treatments have been developed with cure rates exceeding 90%.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

OCTOBER 26, 2017

“The medieval guild system was a primitive networking exercise.” “He that will not apply new remedies must expect new evils; for time is the greatest innovator,” stated Francis Bacon. The major innovation lay in an extraordinary machine already in use in Lucca, about 150 kilometers southwest of Bologna.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 14

Marketing Venture Capitalist Biotechnology IPO 14

Harvard Business Review

JUNE 9, 2017

How the most innovative providers are creating value. Commonly, researchers develop a theory, then build a career gathering support for it. Clinicians working for medical centers or health systems can be in conflict of interest without receiving money from industry. Insight Center. The Leading Edge of Health Care.

Conflict of Interest 8

Conflict of Interest Pharmaceuticals Policies Industry 8

Harvard Business Review

OCTOBER 23, 2014

Used to its full potential, this is predictive medicine — the ability to integrate and analyze known disease characteristics with a specific patient’s history and health status, and use the resulting insights to change outcomes and inform new directions for life sciences research and development. They’re also sharing risk.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. And that's true in many areas: New devices, pharmaceuticals, and surgical techniques regularly get developed and incorporated into practice.

Health Care 14

Health Care Biotechnology Mayo Pharmaceuticals 14

Harvard Business Review

NOVEMBER 12, 2018

With a $1 million price tag, limited data on efficacy and just 700 potential patients in Europe, health systems were unwilling to pay for treatment. Our research on major innovations finds that when disruption occurs, technologies don’t replace technologies; systems replace systems. Something has got to give.

Business Model 9

Business Model Insurance Cost Bond 9

Harvard Business Review

APRIL 19, 2016

has been an innovation superpower. Take a look at any significant innovation, such as an iPhone , and you’ll find that most, if not all, of the technology came from some government program. In the pharmaceutical industry, the monitoring process can be incredibly elaborate. vincent tsui FOR HBR. Since World War II, the U.S.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

MARCH 8, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. We don't understand the business models that will support real public private partnerships in the deployment and sustainability of mHealth systems.

Wireless 14

Wireless Health Care Pharmaceuticals Business Model 14

Harvard Business Review

JANUARY 23, 2015

For example, the group defined the education driver as “the degree to which US elementary through higher education has developed curricula to produce science and technical talent.” Here are a few of the provocative ideas the group advanced: Pharmaceutical and biotech firms will make smaller bets, and more of them.

Kahneman 8

Kahneman Scenario Planning Pharmaceuticals Workshop 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

FEBRUARY 6, 2018

Consider its decision to pursue the market for pharmaceutical distribution, or the recent announcement that it will be teaming up with Berkshire Hathaway and JP Morgan Chase to create joint solutions for reducing the health care spending of more than 1 million employees and their families. Data analytics. Turning itself inside out.

Health Care 9

Health Care Retail Operations Insurance 9

Harvard Business Review

JULY 4, 2017

Tim Cook recently confirmed that Apple is working on ‘autonomous systems.’ Apple is so great at connectivity, aesthetics, and entertainment that any vehicle they develop will incorporate these as table stakes. ’ As usual with Apple, details are sparse, but it’s likely that autonomous cars are part of this.

Transportation 8

Transportation Sports Pharmaceuticals Health Care 8

Harvard Business Review

FEBRUARY 2, 2015

Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. Indeed, in a world where globalization and rapid technological changes are the norm, manufacturing, high-tech development, and innovation clearly require a different level of support.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

MARCH 11, 2013

Apple is probably the most successful and innovative company on earth over the past decade, and it's extremely closed and secretive. It had to pump up the buzz around its platform to encourage its current customers to stay loyal and developers to make apps. Then to your credit, you bring up the paradox yourself. What's up with that?

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15